Stock Scorecard

Stock Summary for Transmedics Group Inc (TMDX) - $134.66 as of 1/12/2026 9:28:09 PM EST

Total Score

13 out of 30

Safety Score

55 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for TMDX

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for TMDX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for TMDX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for TMDX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for TMDX (55 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 9
Stock Price Trend (Max of 10) 10
Book Value (Max of 10) 5
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 4
Trading Volume (Max of 10) 6
Price to Earnings (Max of 10) 2
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Financial Details for TMDX

Company Overview
Ticker TMDX
Company Name Transmedics Group Inc
Country USA
Description TransMedics Group, Inc. (TMDX) is an innovative medical technology company headquartered in Andover, Massachusetts, dedicated to transforming organ transplant therapies for patients suffering from end-stage organ failure. Its proprietary Organ Care System enhances the preservation and functionality of donor organs, significantly improving patient outcomes and expanding the viability period of transplants. As a commercial-stage entity, TransMedics is strategically positioned to leverage the increasing global demand for organ transplants, addressing critical challenges in the transplant landscape and striving to redefine standards in organ care.
Sector Name HEALTHCARE
Industry Name MEDICAL DEVICES
Most Recent Quarter 9/30/2025
Next Earnings Date N/A

Stock Price History
Last Day Price 134.66
Price 4 Years Ago 61.72
Last Day Price Updated 1/12/2026 9:28:09 PM EST
Last Day Volume 570,777
Average Daily Volume 664,485
52-Week High 156.00
52-Week Low 55.00
Last Price to 52 Week Low 144.84%

Valuation Measures
Trailing PE 53.96
Industry PE 56.69
Sector PE 123.98
5-Year Average PE -9.74
Free Cash Flow Ratio 9.87
Industry Free Cash Flow Ratio 27.72
Sector Free Cash Flow Ratio 29.04
Current Ratio Most Recent Quarter 7.69
Total Cash Per Share 13.64
Book Value Per Share Most Recent Quarter 10.40
Price to Book Ratio 13.19
Industry Price to Book Ratio 4.82
Sector Price to Book Ratio 24.69
Price to Sales Ratio Twelve Trailing Months 8.27
Industry Price to Sales Ratio Twelve Trailing Months 4.22
Sector Price to Sales Ratio Twelve Trailing Months 19.33
Analyst Buy Ratings 7
Analyst Strong Buy Ratings 2

Share Statistics
Total Shares Outstanding 34,174,300
Market Capitalization 4,601,911,238
Institutional Ownership 111.26%

Dividends
Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 450.10%
Annual Earnings Growth 241.70%
Reported EPS 12 Trailing Months 2.54
Reported EPS Past Year 2.28
Reported EPS Prior Year 1.01
Net Income Twelve Trailing Months 91,765,000
Net Income Past Year 35,464,000
Net Income Prior Year -25,028,000
Quarterly Revenue Growth YOY 32.20%
5-Year Revenue Growth 79.64%
Operating Margin Twelve Trailing Months 16.20%

Balance Sheet
Total Cash Most Recent Quarter 466,174,000
Total Cash Past Year 336,650,000
Total Cash Prior Year 394,812,000
Net Cash Position Most Recent Quarter -40,511,000
Net Cash Position Past Year -172,661,000
Long Term Debt Past Year 509,311,000
Long Term Debt Prior Year 506,204,000
Total Debt Most Recent Quarter 506,685,000
Equity to Debt Ratio Past Year 0.31
Equity to Debt Ratio Most Recent Quarter 0.41
Total Stockholder Equity Past Year 228,603,000
Total Stockholder Equity Prior Year 137,202,000
Total Stockholder Equity Most Recent Quarter 355,200,000

Free Cash Flow
Free Cash Flow Twelve Trailing Months 120,647,000
Free Cash Flow Per Share Twelve Trailing Months 3.53
Free Cash Flow Past Year -80,941,000
Free Cash Flow Prior Year -192,087,000

Options
Put/Call Ratio 0.47
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 2.02
RSI 0.00
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.00

System
Modified 1/10/2026 9:23:56 AM EST